🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study

RecruitingNAAges 18 Years - anyAllUniversity of Aarhus
NCT07339761 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Despite increasing recognition of sexual dysfunction and sexual distress as important survivorship issues in oncology, research and clinical attention remain uneven across cancer types. This imbalance is particularly evident in bladder cancer, where sexual health has received limited research and clinical attention. However, existing studies demonstrate substantial sexual dysfunction and reduced intimacy among patients following disease and treatment. The treatment of bladder cancer is a multimodal and multidisciplinary discipline. Low-risk non-muscle-invasive bladder cancer (NMIBC) is treated by transurethral resection of the bladder (TURB) alone, while recurrent intermediate- and high-risk NMIBC undergo a combination of TURB and adjuvant intravesical instillation therapy. For patients with muscle-invasive bladder cancer (MIBC) and specific high-risk NMIBC cases, the first-line treatme

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria study 1a: * The participant has one of the following diagnoses and received initial treatment approximately 12 months ago: 1. Non-muscle-invasive bladder cancer treated with transurethral resection of the bladder (TUR-B) 2. Non-muscle-invasive bladder cancer treated with TUR-B and subsequent intravesical instillation therapy with chemotherapy or immunotherapy 3. Muscle-invasive bladder cancer treated with cystectomy (removal of the bladder) * The participant has experienced changes and/or difficulties in sexual function related to the cancer diagnosis and/or its treatment * The participant speaks and understands Danish * The participant is aged 18 years or older * The participant has read and understood the oral and written study information * The participant has provided written informed consent Exclusion Criteria study 1a: * The participant has a history of other cancers located in the pelvic region, including rectal cancer, sarcomas, uterine cancer, cervical cancer, ovarian cancer, prostate cancer, or penile cancer * The participant has a history of breast cancer Inclusion Criteria study 1b: * The participant is diagnosed with Muscle-invasive bladder cancer treated with cystectomy (removal of the bladder) * The participant speaks and understands Danish * The participant is aged 18 years or older * The participant has read and understood the oral and written study information * The participant has provided written informed consent Exclusion Criteria study 1b: * The participant has a history of other cancers located in the pelvic region, including rectal cancer, sarcomas, uterine cancer, cervical cancer, ovarian cancer, prostate cancer, or penile cancer * The participant has a history of breast cancer
💊

What it tests

  • Sexological Support
📍

Where

1 site
Department of Urology, Aarhus University Hospital
Aarhus, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy